While GLP-1s have been widely celebrated for transforming weight loss, some who use the medications find themselves in a less-studied patient category: “nonresponders.” This minority of people haven’t experienced any significant change in weight, even after adjusting their dose or switching brands.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
Stories of progress and joy, delivered every Thursday
